Azenta, Inc., announced the launch of the BioArc Ultra, a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new...
Remix Therapeutics, a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, announced the appointment of...
Frontage Holdings Corporation ("Frontage") is pleased to announce that Mr. Henry Gao has been appointed as its Chief Financial Officer ("CFO"), effective February 1, 2024. As CFO,...
Synthekine Inc., an engineered cytokine therapeutics company, announced a worldwide collaboration with Sanofi to develop and commercialize IL-10 receptor agonists for the treatment of...
Premier Research announced, the appointment of John Ratliff to the position of Chief Executive Officer and Board member. In this position, he succeeds Ludo Reynders,...
